Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Organon & Co. Common Stock
(NY:
OGN
)
15.28
-1.04 (-6.37%)
Official Closing Price
Updated: 7:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Organon & Co. Common Stock
< Previous
1
2
3
4
5
6
Next >
Organon (OGN) Shares Skyrocket, What You Need To Know
February 13, 2025
Shares of pharmaceutical company Organon (NYSE:OGN) jumped 12.5% in the morning session after the company reported fourth-quarter 2024 results that topped analysts' revenue and EPS expectations. While...
Via
StockStory
Topics
Initial Public Offering
Exposures
Securities Market
Organon (NYSE:OGN) Exceeds Q4 Expectations But Full-Year Sales Guidance Misses Expectations Significantly
February 13, 2025
Pharmaceutical company Organon (NYSE:OGN) reported Q4 CY2024 results exceeding the market’s revenue expectations, but sales were flat year on year at $1.59 billion. On the other hand, the company’s...
Via
StockStory
Earnings Scheduled For February 13, 2025
February 13, 2025
Via
Benzinga
Organon (OGN) Q4 Earnings Report Preview: What To Look For
February 12, 2025
Pharmaceutical company Organon (NYSE:OGN) will be reporting earnings tomorrow before market hours. Here’s what investors should know.
Via
StockStory
Looking Into Organon's Recent Short Interest
November 07, 2024
Via
Benzinga
P/E Ratio Insights for Organon
October 02, 2024
Via
Benzinga
3 Cheap High Dividend Stocks For Passive Income
August 30, 2024
These undervalued high yield stocks could return over 10% per year.
Via
Talk Markets
High Dividend 50: Organon & Co.
June 27, 2024
Organon & Co.’s current annual dividend is $1.12 per share. At around $20 per share, Organon stock has a high yield of 5.4%.
Via
Talk Markets
Want $2,000 in Annual Dividends? Invest $11,000 in Each of These 3 Stocks.
January 01, 2025
Via
The Motley Fool
Want $300 in Dividends Every Month? Invest $20,000 in Each of These 3 Stocks
October 24, 2024
These dividend stocks all pay yields of around 6% and higher.
Via
The Motley Fool
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q4
October 22, 2024
Via
Benzinga
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
October 21, 2024
Via
Benzinga
Organon, Howmet Aerospace And More: CNBC's 'Final Trades'
October 03, 2024
On CNBC's "Halftime Report Final Trades," Stephen Weiss of Short Hills Capital Partners named ProShares Short QQQ as his final trade.
Via
Benzinga
Week In Review: Nippon Shinyaku Signs $735 Million Deal For DMD Therapy
September 21, 2024
Japan’s Nippon Shinyaku will acquire European rights for a Duchenne muscular dystrophy disease therapy developed by Capricor Therapeutics of San Diego. Nippon Shinyaku will pay $20 million upfront and...
Via
Talk Markets
Roivant Sciences Offloads Psoriasis Medicine Maker To Organon For Up To $1.2B
September 18, 2024
Organon is set to acquire Roivant Sciences' Dermavant Sciences, known for developing immuno-dermatology treatments, including FDA-approved Vtama cream for plaque psoriasis. The deal, valued up to $1.2...
Via
Benzinga
JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability
September 06, 2024
JP Morgan assesses the specialty pharma sector, highlighting robust fundamentals and new product excitement. Key focus on Teva, Organon, and Viatris.
Via
Benzinga
Organon Stock Sees Relative Strength Rating Rise To 91
August 27, 2024
On Tuesday, Organon[ stock hit an key technical milestone, seeing its Relative Strength Rating jump to 91, up from 88 the day before.
Via
Investor's Business Daily
Organon Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold
August 20, 2024
On Tuesday, generic drug maker Organon stock had its Relative Strength (RS) Rating upgraded to 83, up from 78 a day earlier.
Via
Investor's Business Daily
OGN Stock Earnings: Organon Beats EPS, Misses Revenue for Q2 2024
August 06, 2024
OGN stock results show that Organon beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Jim Cramer Says No To This Health Care Stock, Recommends Holding On To Constellation Energy: 'It's Up A Huge Amount'
July 30, 2024
Jim Cramer said Constellation Energy is a "solar play that is a very good company. It's up a huge amount versus a lot of other stocks."
Via
Benzinga
3 High-Yield Dividend ETFs to Buy to Generate Passive Income
July 06, 2024
These exchange-traded funds should keep the income flowing in regularly.
Via
The Motley Fool
Topics
ETFs
Value Investing Is Back! 3 Stocks With Strong Fundamentals to Buy Now
June 26, 2024
Uncover three top value stocks to buy with robust fundamentals for stable long-term growth amid turbulence.
Via
InvestorPlace
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
June 08, 2024
These stocks offer great dividends and more.
Via
The Motley Fool
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 5% Dividend Yields
May 10, 2024
Via
Benzinga
Organon Beats On Q1, Women's Health Leads the Charge
May 02, 2024
Organon reported 5% increase in Q1 2024 revenue of $1.622 billion, beating consensus. EPS of $1.22 and dividend of $0.28 declared.
Via
Benzinga
OGN Stock Earnings: Organon Beats EPS, Beats Revenue for Q1 2024
May 02, 2024
OGN stock results show that Organon beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
7 Sleeper Stocks to Buy Before Wall Street Wakes Up: April 2024
May 01, 2024
While these sleeper stocks to buy don’t attract the spotlight, the lack of attention makes these ideas even more enticing.
Via
InvestorPlace
3 Healthcare Stocks With the Potential to Triple Your Investment by 2026
May 01, 2024
Learn how these three healthcare stocks offer sharp opportunities in pharmaceuticals, healthcare services, and biotechnology.
Via
InvestorPlace
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
March 13, 2024
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
Turn $500 into a Fortune: 3 Top Stock Picks for March’s Million-Dollar Rally
March 07, 2024
Here are three top stock picks for rally have their grip in travel, packaged foods, meats and pharmaceuticals.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.